explore -WSS

explore

author：Wikipedia 2025-09-03 09:25:20 - browse：69651

A protestor wears a transgender flag at a hearing on banning gender-affirming health care legislation in Missouri. AP Photo/Charlie Riedel

The American Academy of Pediatrics reaffirmed its support for gender-affirming medical care for transgender children on Thursday, even as the treatments face a growing push for bans and restrictions from Republican lawmakers across the U.S.

The board of directors for the group, which represents 67,000 pediatricians, unanimously voted to reaffirm its 2018 position on the treatments. The board also voted to provide additional documents to support pediatricians, including clinical and technical reports, and to conduct an external review of research regarding the care.

“The additional recommendations also reflect the fact that the board is concerned about restrictions to accessing evidence-based health care for young people who need it,” Mark Del Monte, the academy’s CEO, said in a statement released by the group, calling the restrictions enacted by states “unprecedented government intrusion.”

“We therefore need to provide the best and most transparent process possible,” he said.

At least 21 states have now enacted laws restricting or banning gender-affirming medical care for transgender minors, and most of those states face lawsuits. A federal judge struck down Arkansas’ ban as unconstitutional, and federal judges have temporarily blocked bans in Alabama and Indiana.

The judge who struck down Arkansas’ ban cited the position of the groups in his ruling against the ban. Arkansas has appealed the judge’s decision.

People opposed to such treatments for children argue they are too young to make such decisions about their futures.

Every major medical group, including the academy and the American Medical Association, has opposed the bans and has said the treatments are safe if administered properly.

The academy and the AMA support allowing children to seek the medical care, but they don’t offer age-specific guidance.

Previous article： Drug repurposing or repositioning? The language matters
Next article： What will Novo Nordisk's VC do with its influx of cash?

WSS

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

2023 Nobel Prize in Medicine goes to Karikó and Weissman

2023 Nobel Prize in Medicine goes to Karikó and Weissman

RSV injection headlines need to be accurate for good uptake

Nobel honors Karikó and Weissman's enduring partnership

CDC picks Alphabet's Verily for wasterwater surveillance contract

Wikipedia

explore

explore

ChatGPT in medicine: STAT answers readers' burning questions

JPM: CVS says Medicare Advantage patients are impacting profits

DIEP, the 'gold standard' of breast reconstruction, is under threat

The FDA must approve intranasal treatments for anaphylaxis

Moonlake's readout produced a cash windfall. Risks remain

Experts study whether long Covid risk adds up with each reinfection

Peter Hotez and the public health issue of online harassment

WHO recommends second malaria vaccine

In Memoriam: Notable people who died in 2023

GSK Flovent asthma inhalers replaced by authorized generics

Wikipedia

Experts study whether long Covid risk adds up with each reinfection

What will Novo Nordisk's VC do with its influx of cash?

The biotech scorecard for Q1: 17 stock

UCB departs biotech trade group BIO

Stop Congress from blocking public access to science

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

leisure time

explore

leisure time

focus